By redirecting money from its own operating expenses, the international reproductive justice organization has been able to double the number of grantees receiving support through its Ipas Collaborative Fund.
Read MoreGuest contributor Dr. Vanessa Kerry argues that even as philanthropy pledges billions toward climate adaptation and the climate-health nexus, what really matters is how and to whom those dollars are made available.
Read MoreIn this guest article, Celeste Brubaker and Brian Boland argue that the delivery of global humanitarian aid can be much improved if funders focus on paying for results rather than simply backing “activities.”
Read MoremRNA technology promises vaccines that could be easily produced and highly effective against disease, especially in places with low access to medicines. Here’s how the Bill & Melinda Gates Foundation is ramping up its support.
Read MoreFounded by a private equity veteran, Focusing Philanthropy brings a venture-capital-informed approach to the role of philanthropic go-between, routing donor dollars to a carefully curated set of nonprofits.
Read MorePhilanthropy has been slow to recognize the importance of vision care, despite its centrality to global life. There have been exceptions, though. The NGO Orbis International is one focus for funder support.
Read MorePhilanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
Read MoreAs it seeks to expand abortion and contraception access, Ipas is making major changes to its organizational model, in part to bolster a global abortion ecosystem it sees as limited by top-down funding.
Read MoreDespite their insight into affected populations, humanitarian researchers from the Global South remain vastly under-resourced next to their Global North peers. Guest author Isabella Cordua outlines what funders can do to fix that.
Read MoreThe Gates Foundation, Novo Nordisk Foundation and Open Philanthropy are collaborating under a partnership called Pandemic Antiviral Discovery, funding research to develop treatments that may be needed for future pandemics.
Read MorePhilanthropic funding has played a major role in a highly successful international effort to combat a disease that was once widespread across the globe. But the fight isn’t over yet.
Read MorePhilanthropy represents only a fraction of global health spending, and large foundations dominate U.S. giving for global health. Still, COVID-19 has led to an uptick, both from established funding leaders and others.
Read MoreSerious injuries exert a worldwide toll that often escapes the spotlight, with poorer countries bearing the brunt of the problem. Here’s how a group of funders is bankrolling an effort to train surgeons to respond.
Read MoreHealth misinformation is on the rise, and it’s hampering efforts to stop the pandemic. Leading health funders are backing a project that will fund research on misinformation, how it spreads, and what we can do about it.
Read MoreWith omicron looming, foundations like Ford, Rockefeller and Gates are spearheading an international funders’ alliance for vaccine equity. It’s worthy work, but why aren’t more big funders stepping up on global health equity?
Read MoreCan funders back research conducted by Global North institutions in the Global South without becoming extractive? Guest contributor Terry McGovern gives us five ways that work can take place more equitably.
Read MoreAs COVID underscores the need for a far more ambitious agenda on global development, new data from the OECD shows some positive signs around philanthropic engagement—amid the ecosystem’s continuing vulnerabilities.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
